Are you aware of Erdheim-Chester Disease? Let's talk about this rare condition!

Have you ever heard of Erdheim-Chester Disease (ECD)? You may have been a little surprised when you heard this name. Because this is a very rare disease that is seen very rarely in the world. However, since it can affect various organ systems in our body, it is very valuable to be a little aware of this. So today, let's talk about Erdheim-Chester Disease (ECD).

What is Erdheim-Chester disease (ECD)?

Simply put, Erdheim-Chester disease (ECD) is a very rare blood disorder. It belongs to a group of diseases called histiocytosis . Now you may be wondering what these histiocytes are. Histiocytes are a special type of cell in our immune system . They are like little soldiers that protect our bodies. These cells are usually found in places like our bone marrow, blood, skin, lungs, spleen, and liver.

However, in a person with Erdheim-Chester disease (ECD), these histiocytes grow uncontrollably . It's like having too many soldiers. These extra histiocytes start to grow in different parts of the body where they shouldn't. They can then form tumors and damage healthy tissue . This is what happens in ECD.

How common is this disease?

As we have said before, this is a very rare disease . Just think, since the disease was first discovered in 1930, there have been only about 800 cases reported worldwide. However, some doctors believe that this number may be even higher because some people with this disease are underdiagnosed. This may also be due to the fact that countries around the world currently do not have a common system for keeping records of these patients.

Erdheim-Chester disease (ECD) is most common in middle-aged adults . In the United States, the average age of diagnosis is 46 years. However, it has been reported in very young children. Another thing is that men are more likely to develop the disease. It is reported that between 70% and 75% of patients are men.

What are the symptoms?

The way Erdheim-Chester disease (ECD) affects each person is very different . This means that not everyone has the same symptoms. The symptoms depend on which parts of the body are damaged by the excess histiocytes, as we mentioned earlier, and which organ systems are affected. Sometimes, the disease can be present without showing any symptoms (asymptomatic). In that case, the doctor gets a clue about it from a scan (`imaging`) or blood tests (`lab tests`) done for another reason.

Let's look at the organ systems that are mainly affected and the symptoms associated with them.

How it affects bones

ECD can cause abnormal thickening of the bones (osteosclerosis). This can sometimes cause bone pain . The most common symptom of this disease is bone thickening and pain, especially in both legs . This bone thickening can be clearly seen on scans.

Effect on the kidneys

Our kidneys and the surrounding tissue (the `retroperitoneum`) can also be damaged by these histiocytes. This can lead to conditions such as:

• Kidney swelling.
• Kidney atrophy.
• Renal failure.

Effect on the endocrine system (hormone system)

If these histiocytes damage the glands that produce hormones that control various processes in our body, various hormonal problems can arise. Symptoms vary depending on the gland that is damaged.

• If the pituitary gland is damaged: Decreased production of one or more pituitary hormones (`hypopituitarism`).
• If the thyroid gland is damaged: Decreased thyroid hormones (hypothyroidism).
• If the gonads are damaged: Decreased levels of sex hormones (such as testosterone and estrogen) (`hypogonadism`).
• If the adrenal gland is damaged: Decreased adrenal hormones (adrenal insufficiency).

Damage to the pituitary gland can cause a condition called diabetes insipidus , which causes symptoms such as frequent urination and excessive thirst. It has been found that about half of ECD patients also have this condition.

Effect on the nervous system

Our brain and nervous system can also be damaged by these histiocytes. Then you may see symptoms like:

• Loss of balance when walking, problems with coordination (ataxia).
• Slurred speech (dysarthria) due to inability to control muscles during speech.
• Difficulty thinking, concentrating, or remembering.
• Headache.

Effect on the eyes

ECD can affect one or both eyes.

• Yellow, soft lumps on the eyelids (xanthelasma).
• Protrusion of the eyelids (proptosis).
• Eye pain.
• Decreased or loss of vision.

Effect on the respiratory system

Although scans show that the lungs are affected by these histiocytes, symptoms often do not occur . However, if symptoms do occur, they may include:

• Cough.
• Difficulty breathing (dyspnea).

If not treated properly , it can lead to permanent scarring of the lungs (pulmonary fibrosis), a serious condition.

Effect on the cardiovascular system

Your doctor may also see on scans that histiocytes have affected your heart and blood vessels. This can be life-threatening if left untreated. ECD can cause the following:

• Swelling of the sac around the heart (pericardial effusion).
• High blood pressure (renal hypertension) occurs due to restricted blood flow to the kidneys.
• Heart failure.

Effect on the skin

The main symptom seen on the skin is yellow bumps (`xanthelasma`) that appear on the eyelids. In addition, yellow-brown bumps can also be seen in these places:

• On the face.
• On the neck.
• Chest and abdomen (`Torso`).
• In the groin area.

In addition, these excess histiocytes can accumulate and damage tissues in places like the spleen, liver, and bone marrow.

What are the causes of the disease?

We now know that ECD is a disease in which histiocytes multiply uncontrollably, spread, and damage healthy tissues and organs. However, scientists still don't know exactly why these cells grow uncontrollably. However, recent research has found that certain gene mutations play a role.

More than half of people with Erdheim-Chester disease (ECD) have been found to have a mutation in the BRAF gene, which contributes to the uncontrolled growth of histiocytes.

Although the BRAF gene is the most common mutation, scientists have identified several other genetic mutations associated with ECD. These discoveries have allowed scientists to develop treatments that target those mutated genes and stop the abnormal growth of histiocytes.

How is this disease diagnosed?

Because ECD is a very rare disease and symptoms vary from person to person, doctors may not immediately suspect the condition. Therefore, it can take some time to get a diagnosis . You may need to see several doctors.

Your doctor will consider your symptoms along with the results of several other tests to determine whether you have ECD. The following are some of the things that can help you make a diagnosis:

• Imaging procedures: Various scans (X-rays, bone scans, PET scans, CT scans, MRIs) can be used to see where in the body these histiocytes have invaded the tissue. They can also show damage to soft tissues such as the brain, chest, and abdominal organs.
• Laboratory tests:These tests can detect certain problems with organ function (which may be related to ECD), as well as check for things like inflammation, blood cell count abnormalities, and changes in hormone levels.
• Biopsy: A biopsy involves taking a small sample of affected tissue and examining it under a microscope. The cells are then tested for signs of ECD and for genetic mutations such as BRAF. Knowing the characteristics of these cells can help your doctor decide which treatment is best for you.

What are the treatments?

If you have no symptoms and your ECD is not affecting your health, your doctor may decide to monitor your condition. However, most people with ECD will need treatment . Although there is no cure, there are several treatments that can help manage the condition.

Here are the main treatment methods:

• Targeted therapy: This involves using drugs that target the genetic mutations that cause histiocytes to multiply uncontrollably. The FDA has approved a drug called Vemurafenib for ECD patients with the BRAF gene mutation, and a drug called Cobimetinib for those with the MEK gene mutation. Depending on the type of mutation in your cells, your doctor may recommend these or other targeted drugs or drug combinations.
• Immunotherapy: These drugs help our immune system better recognize and fight cancer cells (in this case, abnormal histiocytes). Interferon-alpha is a commonly used immunotherapy drug for ECD.
• Chemotherapy: Chemotherapy uses drugs to kill cancer cells (abnormal cells) throughout the body and stop the growth of tumors. The most common chemotherapy drug used for ECD is cladribine . However, your doctor may recommend other chemotherapy drugs or combinations of drugs.

In addition to these main treatments, your doctor may recommend other treatments to help relieve your symptoms. While these treatments won't stop the histiocytes from invading your tissues, they can help reduce the discomfort you feel.

• Surgery: Surgery may be needed to repair some of the tissue damage caused by ECD. For example, inflammation and damaged tissue can block the tubes that carry urine (ureters). If this happens, surgery may be needed to repair it.
• Radiation therapy:Radiation therapy may be recommended to destroy abnormal cells in a specific area of ​​the body and reduce the uncomfortable symptoms they cause.
• Corticosteroids: These drugs can reduce inflammation caused by the infiltration of histiocytes.

You may also have the opportunity to participate in a clinical trial . A clinical trial is a study that tests the safety and effectiveness of new treatments and new treatment combinations. Ask your doctor if you can participate in a clinical trial for Erdheim-Chester disease (ECD).

Can this be prevented?

Unfortunately, there is no way to prevent Erdheim-Chester disease (ECD). However, the disease can be largely managed with treatment.

How long can you live with the disease?

Your prognosis depends on which parts of your body are affected by the histiocytes and how you respond to treatment. However, with the development of new treatments, such as targeted therapy, the survival outcomes associated with ECD have now improved significantly.

Imagine, in 1996, the five-year survival rate for ECD patients was only 43%. However, according to a recent study, that rate has increased to 83%!

Talk to your doctor about the future course of your disease based on your condition and response to treatment.

When should you see a doctor?

ECD requires ongoing treatment and monitoring . Your doctor will advise you on how often you should see your doctor, and whether you should have scans and blood tests.

Many treatments for ECD can cause unpleasant side effects . In addition to your ECD treatment team, getting help from a palliative care team can help you manage the side effects of these treatments and cope with the stress that comes with the diagnosis.

Finally, the most important thing (Take-Home Message)

Erdheim-Chester disease (ECD) is a condition that affects each person differently, caused by an overproduction of histiocytes, which damage tissue. The signs and symptoms of this disease vary from person to person. These can affect your overall experience, including the treatments available.

But, fortunately, with recent advances, scientists have been able to find treatments that improve the prognosis of ECD.Talk openly with your doctor about the treatment options that are right for you and the results you can expect, based on the specific characteristics of your condition. Remember, even in this rare situation, you can move forward stronger with the right medical advice and support.

` Erdheim-Chester disease, ECD, histiocytosis, rare diseases, genetic mutations, BRAF, symptoms, treatment